Last Update 03 Jun 26
Fair value Decreased 0.62%CVC: Buyback Activity And Major Deal Pipeline Will Support Future Premium Earnings
Analysts have trimmed their price target on CVC Capital Partners by €0.10 to about €16.85, reflecting updated assumptions on revenue growth, profitability and future P/E multiples following recent research updates.
Analyst Commentary
Bullish Takeaways
- Bullish analysts still see upside to the current share price with a price target around €16.85, which signals confidence that current execution can support this level of valuation.
- The use of a specific P/E framework in recent research suggests analysts view earnings visibility as solid enough to anchor their valuation work, rather than relying purely on sentiment.
- Adjustments to assumptions on revenue growth and profitability are being made within an ongoing coverage framework, which indicates that analysts remain engaged and are updating models rather than stepping away from the stock.
- Even after target cuts from higher levels, the maintained positive stance suggests analysts still see the business model as capable of supporting a premium relative to where the shares trade today.
Bearish Takeaways
- Successive reductions in the indicated price target, including a cut from €21.10 to €17.50 and a further trim of €1.50, highlight rising caution around the earnings outlook and valuation support.
- Lower assumed future P/E multiples point to concern that investors may be willing to pay less for each euro of earnings, which can limit share price upside even if the company delivers on its plans.
- Revisions to revenue growth and profitability assumptions suggest analysts are building in more conservative expectations, which can cap near term growth in fair value estimates.
- The gradual step down in targets indicates that analysts see less room for execution missteps, with any shortfall in performance more likely to weigh on valuation than previously assumed.
What's in the News
- International Flavors & Fragrances agreed to sell a majority stake in its food ingredients business to CVC Capital Partners in a deal valued at about US$4.3b, with IFF keeping a 10% stake and a board seat in the new company to support ongoing collaboration, according to recent news reports.
- A CVC led consortium launched a voluntary cash tender offer of about €10.7b to €12.4b to take Italian drugmaker Recordati private at roughly €51.29 per share, a 12.89% premium to the pre announcement close, aiming to delist the company and focus it more tightly on rare disease treatments, according to multiple sources.
- CVC Capital Partners completed the sale of its entire 13.8% holding in Naturgy Energy Group for approximately €4b via an accelerated bookbuild, with the transaction citing strong investor appetite for large energy and infrastructure assets, based on deal reporting.
- CVC announced a share repurchase program of 10,000,000 shares for €350m, with the stated aim of reducing capital and cancelling the repurchased shares, under a plan authorized by the Board of Directors on March 11, 2026.
- CVC appointed John Hourican as Chief Financial Officer and Board member effective September 1, 2026, succeeding long serving CFO Fred Watt, who is set to retire from the role after almost 20 years and then remain as a Senior Advisor, according to company announcements.
Valuation Changes
- Fair Value: Trimmed slightly from €16.95 to about €16.85 per share, reflecting updated modelling assumptions.
- Discount Rate: Eased marginally from 6.64% to about 6.61%, a small adjustment to the required return used in the valuation work.
- Revenue Growth: The assumed long-term revenue growth rate has risen from about 11.78% to roughly 12.70%, reflecting a higher top line trajectory in the latest model.
- Net Profit Margin: The expected net profit margin has been reduced from about 63.11% to roughly 59.98%, indicating a more conservative view on future profitability levels.
- Future P/E: The target future P/E multiple has moved up from about 13.38x to roughly 13.64x, representing a modestly higher valuation multiple applied to projected earnings.
Key Takeaways
- Robust fundraising and strategic expansion into Private Wealth and insurance positions the company for long-term revenue growth and diversified fee income.
- Strategic acquisitions and investments in growth areas like AI and infrastructure could enhance revenue, operational efficiency, and margin expansion.
- Economic uncertainties, geopolitical risks, longer fundraising timelines, and currency fluctuations pose challenges to CVC Capital Partners' earnings stability and revenue growth.
Catalysts
About CVC Capital Partners- A private equity and venture capital firm specializing in middle market secondaries, infrastructure and credit, management buyouts, leveraged buyouts, growth equity, mature, recapitalizations, strip sales, and spinouts.
- The activation of Europe/Americas Fund IX and Asia VI, as well as strong fundraising efforts, suggest robust fee-generating potential in the near future, expected to boost management fee revenues and predictable earnings.
- Strategic expansion into Private Wealth and insurance, with initiatives like CVC-CRED and CVC-PE, highlights a focus on long-term revenue growth and diversification of fee income sources.
- Record levels of deployment across private equity and credit sectors, facilitated by the CVC Network's global reach, position the company to capitalize on market opportunities, potentially enhancing revenue and investment returns.
- Continued investment in growth areas such as Private Wealth, insurance, and AI could lead to operational efficiencies and new revenue streams, supporting margin expansion over time.
- Recent strategic acquisitions and fund launches in infrastructure and secondaries indicate scaling efforts that could lead to significant long-term revenue growth and enhanced EBITDA margins.
CVC Capital Partners Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?
- Analysts are assuming CVC Capital Partners's revenue will grow by 12.7% annually over the next 3 years.
- Analysts assume that profit margins will shrink from 63.9% today to 60.0% in 3 years time.
- Analysts expect earnings to reach €1.6 billion (and earnings per share of €1.18) by about June 2029, up from €1.2 billion today.
- In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 13.7x on those 2029 earnings, up from 12.2x today. This future PE is greater than the current PE for the NL Capital Markets industry at 10.8x.
- Analysts expect the number of shares outstanding to remain consistent over the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 6.61%, as per the Simply Wall St company report.
Risks
What could happen that would invalidate this narrative?- Economic uncertainty and inconsistent activity levels may impact realizations and consequently affect net margins and earnings stability.
- Despite successful fundraising, longer timelines and back-ended processes for future fundraising could pose a risk to predictable revenue streams.
- Concentration in Europe, while offering growth potential, also poses geopolitical risks that might affect long-term revenues and earnings stability.
- Challenges in exiting investments due to subdued strategic buyer and IPO markets could result in lower near-term profit realizations and affect overall earnings.
- Risks associated with currency fluctuations, particularly affecting Asian funds' performance, might challenge the revenue growth and net margins.
Valuation
How have all the factors above been brought together to estimate a fair value?
- The analysts have a consensus price target of €16.85 for CVC Capital Partners based on their expectations of its future earnings growth, profit margins and other risk factors.
- However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of €21.0, and the most bearish reporting a price target of just €12.3.
- In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be €2.7 billion, earnings will come to €1.6 billion, and it would be trading on a PE ratio of 13.7x, assuming you use a discount rate of 6.6%.
- Given the current share price of €13.71, the analyst price target of €16.85 is 18.6% higher.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
Have other thoughts on CVC Capital Partners?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeHow well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.